Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by Stocktreeon Dec 01, 2020 4:51pm

500 Views

Post# 32012121

Yep, sooner then I thought. Sigyn Therapeutics...

Sigyn Therapeutics™ Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma

Not good news for EDT. Despite what our 24/7 BB plant here says, they will have an advantage if their product is successful: it will remove simulaneously endotoxines AND cytokines.

So unless EDT starts being more agressive with its marketing strategy and also accelerates its Phase 3 PMX testing, I fear we could be left with a not so hot product line/business model.

But that was to be expected with their history.

Bullboard Posts

Full Circle Lithium goes global with its battery fire-fighter